A Critical Unmet Need: 40% of Oncologists Advocate for Enhanced Safety Profile in Tyrosine Kinase Inhibitors
Cancer treatment has seen incredible advancements and one shining star in the field is the category of drugs known...
tyrosine kinase inhibitor therapy